Colistin‐Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of BiofilmPseudomonas aeruginosa | Zendy

Gloria Herrmann | Zendy; Liang Yang | Zendy; Hong Wu | Zendy; Zhijun Song | Zendy; Hengzhuang Wang | Zendy; Niels Høiby | Zendy; Martina Ulrich | Zendy; Søren Molin | Zendy; Joachim Riethmüller | Zendy; Gerd Döring | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Colistin‐Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of BiofilmPseudomonas aeruginosa

Author(s) -

Gloria Herrmann,

Liang Yang,

Hong Wu,

Zhijun Song,

Hengzhuang Wang,

Niels Høiby,

Martina Ulrich,

Søren Molin,

Joachim Riethmüller,

Gerd Döring

Publication year - 2010

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/656788

Subject(s) - tobramycin , colistin , pseudomonas aeruginosa , biofilm , cystic fibrosis , antibiotics , microbiology and biotechnology , medicine , aminoglycoside , gentamicin , biology , bacteria , genetics

Antibiotic combination therapy might be more efficient than single antibiotics to combat Pseudomonas aeruginosa biofilms in the airways of patients with cystic fibrosis. We tested the ability of colistin sulphate-tobramycin combinations and single antibiotics to kill P. aeruginosa biofilms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research